FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders

• Main Authors: Austin Lui (Author), Jordan Vanleuven (Author), David Perekopskiy (Author), Dewey Liu (Author), Desiree Xu (Author), Omar Alzayat (Author), Taiseer Elgokhy (Author), Timothy Do (Author), Meghan Gann (Author), Ryan Martin (Author), Da-Zhi Liu (Author)
• Format: Book
• Published: MDPI AG, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cancers and neurological disorders are two major types of diseases. We previously developed a new concept termed "Aberrant Cell Cycle Diseases" (ACCD), revealing that these two diseases share a common mechanism of aberrant cell cycle re-entry. The aberrant cell cycle re-entry is manifested...